Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Pharmaceuticals 2010, 3(4), 782-794; doi:10.3390/ph3040782
Article

Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics

1,2,*  and 1
Received: 18 January 2010; in revised form: 9 March 2010 / Accepted: 22 March 2010 / Published: 24 March 2010
(This article belongs to the Special Issue Personalized Medicine)
View Full-Text   |   Download PDF [125 KB, uploaded 24 March 2010]
Abstract: Increasing evidence for the role of pharmacogenetics in treatment resistance to the antiplatelet agent clopidogrel has been gained during the last years. Apart from CYP2C19 genetic polymorphisms, nongenetic factors, particularly drug-drug interactions, age and other clinical characteristics influence the interindividual variability in clopidogrel response to varying degrees. The present article reviews the so far accumulated evidence on the role of pharmacogenetic traits influencing CYP-activity as determinants of the antiplatelet response to clopidogrel, and its clinical implications. The genetic variation in CYP2C19 activity seems to influence short- and long-term antithrombotic effects of clopidogrel to a substantial extent. Prediction models for clopidogrel non-responsiveness that include CYP2C19 genotyping together with relevant non-genetic risk factors are needed to be verified for their potential benefit in individualization of antithrombotic therapy.
Keywords: clopidogrel; CYP2C19; antiplatelet response; pharmacogenetics clopidogrel; CYP2C19; antiplatelet response; pharmacogenetics
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Dahl, M.-L.; Gunes, A. Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics. Pharmaceuticals 2010, 3, 782-794.

AMA Style

Dahl M-L, Gunes A. Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics. Pharmaceuticals. 2010; 3(4):782-794.

Chicago/Turabian Style

Dahl, Marja-Liisa; Gunes, Arzu. 2010. "Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics." Pharmaceuticals 3, no. 4: 782-794.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert